Discontinuation report MINT-IRBESARTAN/HCTZ
Report ID | 143959 |
Drug Identification Number | 02393026 |
Brand name | MINT-IRBESARTAN/HCTZ |
Common or Proper name | Irbesartan HCTZ |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE IRBESARTAN |
Strength(s) | 25MG 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-07-08 |
Remaining supply date | 2021-08-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2021-08-11 | French | Compare |
v1 | 2021-08-11 | English | Compare |
Showing 1 to 2 of 2